PHARMAXIS COMMENCES OPERATIONS IN EUROPE

Specialist pharmaceutical company Pharmaxis Ltd announced today that it has appointed Mark Sanders as its European Regional Director, and has established a subsidiary company to serve the European market based in the United Kingdom. This first overseas management appointment is timed to prepare the markets and partnerships necessary for the commercial launch of Pharmaxis' first product, Aridol, later this year.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-06-2006/0004275290&EDATE=)